Dissecting pseudoaneurysms: predictors of symptom occurrence, enlargement, clinical outcome, and treatment
Search for other papers by Badih Daou in
Current site
Google Scholar
PubMed
Search for other papers by Christine Hammer in
Current site
Google Scholar
PubMed
Search for other papers by Nohra Chalouhi in
Current site
Google Scholar
PubMed
Search for other papers by Robert M. Starke in
Current site
Google Scholar
PubMed
Search for other papers by Pascal Jabbour in
Current site
Google Scholar
PubMed
Search for other papers by Robert H. Rosenwasser in
Current site
Google Scholar
PubMed
Search for other papers by Stavropoula Tjoumakaris in
Current site
Google Scholar
PubMed
OBJECTIVE
Dissection of the carotid and vertebral arteries can result in the development of aneurysmal dilations. These dissecting pseudoaneurysms can enlarge and cause symptoms. The objective of this study is to provide insight into the progression of dissecting pseudoaneurysms and the treatments required to manage them.
METHODS
A review of the electronic medical records was conducted to detect patients with carotid and vertebral artery dissection. An imaging review was conducted to identify patients with dissecting pseudoaneurysms. One hundred twelve patients with 120 dissecting pseudoaneurysms were identified. Univariate and multivariate analyses were conducted to assess the factors associated with undergoing further interventions other than medical treatment, pseudoaneurysm enlargement, pseudoaneurysms resulting in ischemic and nonischemic symptoms, and clinical outcome.
RESULTS
Overall, 18.3% of pseudoaneurysms were intracranial and 81.7% were extracranial, and the average size was 7.3 mm. The mean follow-up time was 29.3 months; 3.3% of patients had a recurrent transient ischemic attack, no patients had a recurrent stroke, and 14.2% of patients had recurrence of nonischemic symptoms (headache, neck pain, Horner syndrome, or cranial nerve palsy). Follow-up imaging demonstrated that 13.8% of pseudoaneurysms had enlarged, 30.2% had healed, and 56% had remained stable. In total, 20.8% of patients had an intervention other than medical treatment. Interventions included stenting, coiling, flow diversion, and clipping. Predictors of intervention included increasing size, size > 10 mm, location in the C2 (petrous) segment of the internal carotid artery (ICA), younger age, hyperlipidemia, pseudoaneurysm enlargement, and any symptom development. Significant predictors of enlargement included smoking, history of trauma, C2 location, hyperlipidemia, and larger initial pseudoaneurysm size. Predictors of pseudoaneurysm resulting in recurrent ischemic and nonischemic symptoms included increasing size and location in the petrous segment of the ICA. Smoking was a predictor of unfavorable outcome.
CONCLUSIONS
Dissecting pseudoaneurysms have a benign course and most will not cause symptoms or enlarge on follow-up. Medical treatment can be a sufficient, initial treatment for dissecting pseudoaneurysms.
ABBREVIATIONS
ICA = internal carotid artery; MRA = MR angiography; mRS = modified Rankin Scale; TIA = transient ischemic attack.
© Copyright 1944-2024 American Association of Neurological Surgeons